📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

GluCl.Cre ON enables selective inhibition of molecularly defined pain circuits. (2023)

First Author: Middleton SJ

Attributed to: Defining the primary afferent circuitry that drives neuropathic pain funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/j.pain.0000000000002976

PubMed Identifier: 37366588

Publication URI: http://europepmc.org/abstract/MED/37366588

Type: Journal Article/Review

Volume: 164

Parent Publication: Pain

Issue: 12

ISSN: 0304-3959